EBS

#2665
Emergent Biosolutions, Inc.
8.0700 USD
-0.68%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
8.0550
8.1200
Годовой диапазон
7.8100
11.4600
Дневное изменение
-0.68%
Месячное изменение
-24.72%
6-месячное изменение
-24.72%
Годовое изменение
-24.72%
Предыдущее закрытие
8.1250
Open
8.0800
Bid
8.0700
Ask
8.0730
Low
8.0550
High
8.1200
Объем
356
Open full chart

Financials

Overview Отчетность Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Emergent BioSolutions Inc

Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded.

Новости